[go: up one dir, main page]

ITMI940025A0 - Derivati di piperazin e piperidinisossazolo - Google Patents

Derivati di piperazin e piperidinisossazolo

Info

Publication number
ITMI940025A0
ITMI940025A0 ITMI940025A ITMI940025A ITMI940025A0 IT MI940025 A0 ITMI940025 A0 IT MI940025A0 IT MI940025 A ITMI940025 A IT MI940025A IT MI940025 A ITMI940025 A IT MI940025A IT MI940025 A0 ITMI940025 A0 IT MI940025A0
Authority
IT
Italy
Prior art keywords
piperidinisoxazole
piperazin
derivatives
Prior art date
Application number
ITMI940025A
Other languages
English (en)
Inventor
Mario Varasi
Paolo Pevarello
Raffaella Amici
Nicola Carfagna
Alberto Bonsignori
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI940025A0 publication Critical patent/ITMI940025A0/it
Publication of ITMI940025A1 publication Critical patent/ITMI940025A1/it
Application granted granted Critical
Publication of IT1269178B publication Critical patent/IT1269178B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ITMI940025A 1993-01-19 1994-01-12 Derivati di piperazin- e piperidinisossazolo IT1269178B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9300950A GB2274282B (en) 1993-01-19 1993-01-19 Piperazine-and piperidine-isoxazole derivatives

Publications (3)

Publication Number Publication Date
ITMI940025A0 true ITMI940025A0 (it) 1994-01-12
ITMI940025A1 ITMI940025A1 (it) 1995-07-12
IT1269178B IT1269178B (it) 1997-03-21

Family

ID=10728919

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI940025A IT1269178B (it) 1993-01-19 1994-01-12 Derivati di piperazin- e piperidinisossazolo

Country Status (4)

Country Link
JP (1) JPH06247965A (it)
DE (1) DE4401159A1 (it)
GB (1) GB2274282B (it)
IT (1) IT1269178B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100616099B1 (ko) * 2004-09-20 2006-08-28 한국과학기술연구원 Ｔ-타입 칼슘채널 길항제로 유효한 신규 피페라지닐알킬이소옥사졸 유도체
US20100022590A1 (en) * 2008-01-17 2010-01-28 Biovitrum Ab (Publ.) Novel compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515093A1 (de) * 1985-04-26 1986-10-30 Hoechst Ag, 6230 Frankfurt 4-aminoalkylidensubstituierte 3-aryl-5(4h)-isoxazolone, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung

Also Published As

Publication number Publication date
GB2274282A (en) 1994-07-20
DE4401159A1 (de) 1994-07-21
IT1269178B (it) 1997-03-21
GB9300950D0 (en) 1993-03-10
ITMI940025A1 (it) 1995-07-12
JPH06247965A (ja) 1994-09-06
GB2274282B (en) 1996-08-14

Similar Documents

Publication Publication Date Title
IT1266582B1 (it) Derivati (di)azacicloesanici e diazacicloeptanici
ITMI920408A1 (it) Derivati benzopiranici e benzotiopiranici
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
FI961599A7 (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
ITMI951020A0 (it) Derivati di diarildiammine
FI961939A7 (fi) Antitromboottiset amidinofenyylialaniini- ja amidinopyridyylialaniinijohdannaiset
MX9203576A (es) Derivados de 3-amido pirazol y composiciones farmaceuticas que los contienen.
FI932722A0 (fi) Glukagonlika peptider och insulinotropinderivat
MA23226A1 (fr) Derives optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-
MA22747A1 (fr) Derives de 2-imidazoline -5-one et 2-imidazoline-5-thiones fongicides
NO944838D0 (no) Arabinogalaktanderivater og anvendelser derav
IT1226389B (it) Nuovi derivati ammidinici e guanidinici
ITMI941463A0 (it) Derivati eterociclo-condensatori di morfinoidi
NO922934D0 (no) Cykloheksan- og tetrahydropyranderivater
MA22916A1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
FI942294A7 (fi) Bentsopyraanijohdannaiset ja niiden käyttö
IT8848618A0 (it) Derivati di lisogangliosidi
ITTO920114A1 (it) Derivati bis-tetrazolici ad attivita' antiallergica e citoprotettiva
ITMI940025A0 (it) Derivati di piperazin e piperidinisossazolo
ITMI941191A0 (it) 1-b-metil-2-tiol carbapen derivati
ITMI931678A1 (it) Derivati benzossazinonici e benzotiazinonici terapeuticamente attivi
ITRM920060A1 (it) Xenocollagene e derivati
ITPD930045A0 (it) Nuovi derivati o-solfatati di gangliosidi e lisogangliosidi
ITMI931727A0 (it) Derivati di 5-isochinolinsolfonammidi
ITMI941462A0 (it) Derivati eterociclo-condensati di morfinoidi

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971231